Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities
Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities have?
Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities has 6 citations in the OpenAlex counts ScholarIQ stores.
When was Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities published?
Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities has 2022 year in the ScholarIQ index.
What is the open-access status of Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities?
Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities has green oa status in the ScholarIQ index.
What is the DOI of Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities?
The DOI for Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities is on the source record.
What is the PMID of Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities?
The PMID for Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities is on the source record.
What is the OpenAlex record for Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities?
The OpenAlex for Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities is on the source record.